沙美特罗氟替卡松粉吸入剂在儿童哮喘治疗中的临床疗效观察

Clinical study on Salmeterol fluticasone propionate powder inhalation in the treatment of child asthma

目的观察沙美特罗氟替卡松粉吸入剂(舒利迭)在治疗儿童哮喘中的临床疗效。方法将130例患有哮喘的儿童随机分为研究组和对照组,每组65例,所有患儿均停用原来治疗哮喘的药物,研究组给予沙美特罗氟替卡松粉吸入剂,对照组给予氟替卡松(辅舒酮)进行治疗。结果患儿在接受药物治疗后的肺功能有明显的改善,且研究组改善更为明显。研究组患者的有效率明显高于对照组。两组差异均具有统计学意义(P<0.05)。结论沙美特罗氟替卡松粉吸入剂能够很好地治疗儿童哮喘,对缓解症状和改善肺功能均能起到良好效果。

Objective To observe the clinical effects of Salmeterol fluticasone propionate powder inhalation in the treatment of children asthma.Methods The 130 children who suffered from asthma were divided randomly into two groups,study group and control group respectively 65 cases.Study group was given Salmeterol fluticasone propionate powder inhalation.Control group was given Flixotide.Results After treatment the lung function had remarkably improved than before the treatment.And study group was more remarkably improved than control group.The effective rate of study group was higher than that of control group.All the difference had statistics significance（P 0.05）.Conclusion Salmeterol fluticasone propionate powder inhalation has good effect on treatment of children asthma,especially benefit to symptom control and improvement of lung function.